A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
When it comes to medically assisted weight loss, there’s two main schools of thought: either weight loss drugs, like the ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART DISEASE AFTER STUDIES LAST FALL. THAT SHOWED ABOUT A 20% REDUCTION IN ...
SAN FRANCISCO, CA / ACCESS Newswire / January 21, 2025 / Gala introduces a groundbreaking digital health platform that ...
Commonly used diabetes drugs could lower the risk of cardiometabolic conditions but heighten the risk of gastrointestinal and ...
Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...
“GLP1s represent a new landscape ... dementia-protecting benefit when they found participants taking GLP-1 drugs had a decreased risk of neurocognitive conditions such as dementia and Alzheimer ...
Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback